Zhejiang Conba Pharmaceutical Co.,Ltd.’s Net Profit Rose 130.4% in First Three Quarters of 2023

Zhejiang Conba Pharmaceutical Co.,Ltd. (浙江康恩贝制药股份有限公司) (600572.SH) reported a net profit of 699.9 million yuan in the first three quarters of 2023, up 130.4% year-on-year.

Meanwhile, the company posted 5.2 billion yuan in revenue, up 15.5% year-on-year.

At the end of the reporting period, it had 11.2 billion yuan in total assets and 3.6 billion yuan in total liabilities, with a liability-to-asset ratio of 32.7%.